FGFR1 and hypoparathyroidism-retardation-dysmorphism syndrome: Consequently, our findings highlighted the enrichment of FGFR1+PDGFRβ+ myCAFs in HRD tumors and identified the unique physical barrier formed by indolent CAFs obstructing immune cell infiltration in HRP tumors.